Concepedia

Fabian Wesseler

FW

Statistics

Publications

5

Citations

122

H-Index

5

Active since

2018

Affiliations

Christian-Albrechts-Universität zu Kiel(Current)

TU Dortmund University

Max Planck Institute of Molecular Physiology

German Centre for Cardiovascular Research

Nottingham Trent University

Fabian Wesseler is an author at Christian-Albrechts-Universität zu Kiel specializing in medicinal chemistry, pharmacology, and osteogenesis.

ORCID

Publications per year

2018–2022

5

Publications

5

Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε

Balbina García-Reyes, Lydia Witt, Björn Jansen et al. · Journal of Medicinal Chemistry · 2018 · 62 citations · Full text

, , +14

The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation

Jana Flegel, Saad Shaaban, Zhi Jun Jia et al. · Journal of Medicinal Chemistry · 2022 · 26 citations · Full text

, , +17

Probing Embryonic Development Enables the Discovery of Unique Small-Molecule Bone Morphogenetic Protein Potentiators

Fabian Wesseler, Daniel Riege, Mahesh Puthanveedu et al. · Journal of Medicinal Chemistry · 2022 · 12 citations · Full text

, , +17

Phenotypic Discovery of Triazolo[1,5-<i>c</i>]quinazolines as a First-In-Class Bone Morphogenetic Protein Amplifier Chemotype

Fabian Wesseler, Stefan Lohmann, Daniel Riege et al. · Journal of Medicinal Chemistry · 2022 · 12 citations · Full text

, , +17

Toward Second‐Generation Cardiomyogenic and Anti‐cardiofibrotic 1,4‐Dihydropyridine‐Class TGFβ Inhibitors

Daniel Längle, Tessa Werner, Fabian Wesseler et al. · ChemMedChem · 2019 · 10 citations

, , +11

1–5 of 5